AUB
CRSP icon

Atlantic Union Bankshares’s CRISPR Therapeutics CRSP Stock Holding History

Atlantic Union Bankshares’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Buy
2,818
+166
+6% +$8.76K ﹤0.01% 673
2025
Q4 		$139K Sell
2,652
-233
-8% -$14K ﹤0.01% 663
2025
Q3 		$187K Buy
2,885
+2,203
+323% +$126K ﹤0.01% 613
2025
Q2 		$33.2K Buy
+682
New +$26.4K ﹤0.01% 734

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlantic Union Bankshares's CRSP Position: Q1 2026 in Review

Atlantic Union Bankshares increased its CRISPR Therapeutics (CRSP) stake by 6.3% in Q1 2026, buying an estimated $8.76K and bringing the position to 2,818 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Atlantic Union Bankshares first reported a position in CRSP in Q2 2025 and has held it in 4 quarters since. The position peaked at $187K in Q3 2025. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Atlantic Union Bankshares held 2,818 shares of CRISPR Therapeutics worth $134K as of Q1 2026.
  • Atlantic Union Bankshares bought 166 CRISPR Therapeutics shares in Q1 2026, an estimated $8.76K.
  • CRISPR Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #673 holding.
  • Atlantic Union Bankshares first reported a position in CRISPR Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Atlantic Union Bankshares's CRISPR Therapeutics position peaked at $187K in Q3 2025.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.